ID   AGA_ANOGA               Reviewed;          84 AA.
AC   Q7Q3J5;
DT   27-NOV-2024, integrated into UniProtKB/Swiss-Prot.
DT   09-JAN-2007, sequence version 3.
DT   18-JUN-2025, entry version 114.
DE   RecName: Full=Agaphelin {ECO:0000303|PubMed:25211214, ECO:0000303|PubMed:32201094, ECO:0000303|PubMed:33401017};
DE   Flags: Precursor;
GN   ORFNames=AgaP_AGAP007907 {ECO:0000312|EMBL:EAA12792.3};
OS   Anopheles gambiae (African malaria mosquito).
OC   Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota;
OC   Neoptera; Endopterygota; Diptera; Nematocera; Culicoidea; Culicidae;
OC   Anophelinae; Anopheles.
OX   NCBI_TaxID=7165 {ECO:0000312|EMBL:EAA12792.3};
RN   [1] {ECO:0000312|Proteomes:UP000007062}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=PEST {ECO:0000312|Proteomes:UP000007062};
RX   PubMed=12364791; DOI=10.1126/science.1076181;
RA   Holt R.A., Subramanian G.M., Halpern A., Sutton G.G., Charlab R.,
RA   Nusskern D.R., Wincker P., Clark A.G., Ribeiro J.M.C., Wides R.,
RA   Salzberg S.L., Loftus B.J., Yandell M.D., Majoros W.H., Rusch D.B., Lai Z.,
RA   Kraft C.L., Abril J.F., Anthouard V., Arensburger P., Atkinson P.W.,
RA   Baden H., de Berardinis V., Baldwin D., Benes V., Biedler J., Blass C.,
RA   Bolanos R., Boscus D., Barnstead M., Cai S., Center A., Chaturverdi K.,
RA   Christophides G.K., Chrystal M.A.M., Clamp M., Cravchik A., Curwen V.,
RA   Dana A., Delcher A., Dew I., Evans C.A., Flanigan M.,
RA   Grundschober-Freimoser A., Friedli L., Gu Z., Guan P., Guigo R.,
RA   Hillenmeyer M.E., Hladun S.L., Hogan J.R., Hong Y.S., Hoover J.,
RA   Jaillon O., Ke Z., Kodira C.D., Kokoza E., Koutsos A., Letunic I.,
RA   Levitsky A.A., Liang Y., Lin J.-J., Lobo N.F., Lopez J.R., Malek J.A.,
RA   McIntosh T.C., Meister S., Miller J.R., Mobarry C., Mongin E., Murphy S.D.,
RA   O'Brochta D.A., Pfannkoch C., Qi R., Regier M.A., Remington K., Shao H.,
RA   Sharakhova M.V., Sitter C.D., Shetty J., Smith T.J., Strong R., Sun J.,
RA   Thomasova D., Ton L.Q., Topalis P., Tu Z.J., Unger M.F., Walenz B.,
RA   Wang A.H., Wang J., Wang M., Wang X., Woodford K.J., Wortman J.R., Wu M.,
RA   Yao A., Zdobnov E.M., Zhang H., Zhao Q., Zhao S., Zhu S.C., Zhimulev I.,
RA   Coluzzi M., della Torre A., Roth C.W., Louis C., Kalush F., Mural R.J.,
RA   Myers E.W., Adams M.D., Smith H.O., Broder S., Gardner M.J., Fraser C.M.,
RA   Birney E., Bork P., Brey P.T., Venter J.C., Weissenbach J., Kafatos F.C.,
RA   Collins F.H., Hoffman S.L.;
RT   "The genome sequence of the malaria mosquito Anopheles gambiae.";
RL   Science 298:129-149(2002).
RN   [2] {ECO:0000312|EMBL:EAA12792.3}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=PEST {ECO:0000312|EMBL:EAA12792.3};
RX   PubMed=17210077; DOI=10.1186/gb-2007-8-1-r5;
RA   Sharakhova M.V., Hammond M.P., Lobo N.F., Krzywinski J., Unger M.F.,
RA   Hillenmeyer M.E., Bruggner R.V., Birney E., Collins F.H.;
RT   "Update of the Anopheles gambiae PEST genome assembly.";
RL   Genome Biol. 8:R5.1-R5.13(2007).
RN   [3] {ECO:0000305}
RP   FUNCTION, INTERACTION WITH HOST ELANE, AND INDUCTION (MICROBIAL INFECTION).
RX   PubMed=25211214; DOI=10.1371/journal.ppat.1004338;
RA   Waisberg M., Molina-Cruz A., Mizurini D.M., Gera N., Sousa B.C., Ma D.,
RA   Leal A.C., Gomes T., Kotsyfakis M., Ribeiro J.M., Lukszo J., Reiter K.,
RA   Porcella S.F., Oliveira C.J., Monteiro R.Q., Barillas-Mury C., Pierce S.K.,
RA   Francischetti I.M.;
RT   "Plasmodium falciparum infection induces expression of a mosquito salivary
RT   protein (Agaphelin) that targets neutrophil function and inhibits
RT   thrombosis without impairing hemostasis.";
RL   PLoS Pathog. 10:e1004338-e1004338(2014).
RN   [4]
RP   FUNCTION.
RX   PubMed=32201094; DOI=10.1016/j.imbio.2020.151937;
RA   Favarin D.C., Pereira A.B.M., Francischetti I.M.B., da Silva M.V.,
RA   Rodrigues V. Jr., da Silva P.R., Valenzuela J.G., Teixeira D.N.S.,
RA   Oliveira C.J.F., Rogerio A.P.;
RT   "Agaphelin modulates the activation of human bronchial epithelial cells
RT   induced by lipopolysaccharide and IL-4.";
RL   Immunobiology 225:151937-151937(2020).
RN   [5]
RP   FUNCTION.
RX   PubMed=33401017; DOI=10.1016/j.bbi.2020.12.027;
RA   Leinweber J., Mizurini D.M., Francischetti I.M.B., Fleischer M.,
RA   Hermann D.M., Kleinschnitz C., Langhauser F.;
RT   "Elastase inhibitor agaphelin protects from acute ischemic stroke in mice
RT   by reducing thrombosis, blood-brain barrier damage, and inflammation.";
RL   Brain Behav. Immun. 93:288-298(2021).
CC   -!- FUNCTION: Functions as a slow and tight inhibitor of host neutrophil
CC       elastase (ELANE) (PubMed:25211214). Inhibits host proteinase 3 (PRTN3)
CC       and chymotrypsin (PubMed:25211214). Does not inhibit other host
CC       proteases involved in coagulation or inflammation, such as cathepsin G
CC       (CTSG), trypsin, chymase, matriptase, beta-tryptase, kallikrein,
CC       urokinase-type plasminogen activator (PLAU), coagulation factors Xa
CC       (F10), XIa (F11), XIIa (F12), plasmin (PLG), thrombin (F2) and tissue-
CC       type plasminogen activator (PLAT) (PubMed:25211214). Inhibits host
CC       neutrophil chemotaxis induced by N-formylmethionine-leucyl-
CC       phenylalanine (fMLP) in vitro (PubMed:25211214). Inhibits ELANE-
CC       mediated potentiation of platelet aggregation induced by CTSG in the
CC       host (PubMed:25211214). Does not affect CTSG- or collagen-induced
CC       platelet aggregation (PubMed:25211214). Blocks cleavage of tissue
CC       factor pathway inhibitor (TFPI) by ELANE in the host (PubMed:25211214).
CC       Inhibits neutrophil-induced coagulation in the host by interfering with
CC       neutrophil extracellular traps (NET) formation (PubMed:25211214).
CC       Exhibits anti-inflammatory activity (PubMed:32201094, PubMed:33401017).
CC       Reduces ischemia-induced activation of MAPK and NF-kappa-B pathways in
CC       the host (PubMed:33401017). Decreases CCL2 and IL8 production in
CC       IL4- or lipopolysaccharide (LPS)-stimulated host epithelial cells
CC       (PubMed:32201094). Reduces caspase-3 (CASP3)-dependent apoptosis in
CC       damaged host tissues (PubMed:33401017). {ECO:0000269|PubMed:25211214,
CC       ECO:0000269|PubMed:32201094, ECO:0000269|PubMed:33401017}.
CC   -!- SUBUNIT: Interacts with human ELANE. {ECO:0000269|PubMed:25211214}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305}.
CC   -!- INDUCTION: (Microbial infection) Up-regulated in salivary gland
CC       following infection with Plasmodium falciparum.
CC       {ECO:0000269|PubMed:25211214}.
CC   -!- MISCELLANEOUS: Reduces inflammation and neutrophil accumulation in a
CC       mouse model of acute inflammation (PubMed:25211214). Prevents thrombus
CC       formation in FeCl(3)-induced carotid artery thrombosis model in mice
CC       without impairing hemostasis (PubMed:25211214). Protects mice from
CC       experimental ischemic stroke by reducing local thrombus formation,
CC       blood-brain barrier damage and inflammatory responses in brain
CC       (PubMed:33401017). {ECO:0000269|PubMed:25211214,
CC       ECO:0000269|PubMed:33401017}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AAAB01008964; EAA12792.3; -; Genomic_DNA.
DR   RefSeq; XP_317576.3; XM_317576.3.
DR   AlphaFoldDB; Q7Q3J5; -.
DR   SMR; Q7Q3J5; -.
DR   FunCoup; Q7Q3J5; 7.
DR   PaxDb; 7165-AGAP007907-PA; -.
DR   EnsemblMetazoa; AGAP007907-RA; AGAP007907-PA; AGAP007907.
DR   KEGG; aga:1278048; -.
DR   VEuPathDB; VectorBase:AGAMI1_010584; -.
DR   VEuPathDB; VectorBase:AGAP007907; -.
DR   eggNOG; ENOG502T6W0; Eukaryota.
DR   HOGENOM; CLU_169765_5_0_1; -.
DR   OMA; EMASCAC; -.
DR   Proteomes; UP000007062; Chromosome 3R.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0030414; F:peptidase inhibitor activity; IDA:UniProtKB.
DR   GO; GO:0004867; F:serine-type endopeptidase inhibitor activity; IEA:UniProtKB-KW.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR   GO; GO:0035899; P:suppression of blood coagulation in another organism; IDA:UniProtKB.
DR   CDD; cd00104; KAZAL_FS; 1.
DR   Gene3D; 3.30.60.30; -; 1.
DR   InterPro; IPR002350; Kazal_dom.
DR   InterPro; IPR036058; Kazal_dom_sf.
DR   InterPro; IPR053265; Serpin.
DR   PANTHER; PTHR21131:SF0; GEO10195P1-RELATED; 1.
DR   PANTHER; PTHR21131; SERINE-TYPE ENDOPEPTIDASE INHIBITOR; 1.
DR   Pfam; PF00050; Kazal_1; 1.
DR   SMART; SM00280; KAZAL; 1.
DR   SUPFAM; SSF100895; Kazal-type serine protease inhibitors; 1.
DR   PROSITE; PS00282; KAZAL_1; 1.
DR   PROSITE; PS51465; KAZAL_2; 1.
PE   1: Evidence at protein level;
KW   Blood coagulation cascade inhibiting toxin; Disulfide bond; Glycoprotein;
KW   Hemostasis impairing toxin; Platelet aggregation inhibiting toxin;
KW   Protease inhibitor; Reference proteome; Secreted;
KW   Serine protease inhibitor; Signal; Toxin.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000255"
FT   CHAIN           27..84
FT                   /note="Agaphelin"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_5014588100"
FT   DOMAIN          29..82
FT                   /note="Kazal-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00798"
FT   SITE            39..40
FT                   /note="Reactive bond"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00798"
FT   CARBOHYD        49
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   DISULFID        35..60
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00798"
FT   DISULFID        37..56
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00798"
FT   DISULFID        45..80
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00798"
SQ   SEQUENCE   84 AA;  9059 MW;  16ED058D25B30FE5 CRC64;
     MKMRVHLLAV SVLLVVLALQ TTPAEADINS EMATCACQLI YRPVCASNNE SYSNECVLKC
     ASETPTGRSI GLHKVKDGNC NGEF
//
